The global market for Radiological Marker was valued at US$ 4438 million in the year 2024 and is projected to reach a revised size of US$ 7270 million by 2031, growing at a CAGR of 7.4% during the forecast period.

Radiological Marker Market

Radiological Marker refers to a class of diagnostic products in which radioactive isotopes are used to label molecules, drugs, antibodies, or bioactive substances to enable precise visualization in medical imaging. By exploiting the biodistribution characteristics of radionuclides, these markers generate high-resolution images through PET and SPECT, allowing clinicians to detect metabolic changes, lesion distribution, and functional status. Radiological markers are widely applied in oncology, cardiovascular diseases, neurodegenerative conditions, inflammation, and metabolic disorders, forming a cornerstone of modern molecular imaging. With high sensitivity, high specificity, and functional imaging capability, they are indispensable tools in precision medicine, drug development, and early diagnostics, driving global healthcare toward earlier detection, higher accuracy, and personalized decision-making.The average gross profit margin of this product is 65%.

As global precision medicine advances, radiological markers are experiencing strong momentum due to their essential role in targeted imaging, functional diagnostics, and therapy monitoring. Growing investments in imaging infrastructure worldwide are increasing the need for highly specific and stable nuclear medicine markers in hospitals and research institutes. Meanwhile, pharmaceutical and biotech companies are expanding their use of radiological markers for drug imaging and companion diagnostics, making them critical evaluation tools in innovative drug development. Clearer regulatory frameworks for nuclear medicine technologies are also creating a more favorable environment for industry expansion.

Despite robust potential, the industry faces substantial challenges. R&D of radiological markers requires multidisciplinary capabilities across chemistry, nuclear medicine, and pharmaceutics, leading to high technical barriers and long validation cycles. Isotope supply chains are highly dependent on specialized production and regulatory systems, making them vulnerable to international capacity constraints and compliance risks. Regulatory differences across countries add further complexity to product approval and commercialization. As leading companies increase investments, competition is shifting toward technology-intensive differentiation, placing pressure on smaller players to balance innovation speed and cost efficiency.

Demand from hospitals, imaging centers, and research institutions is rapidly shifting from conventional general-purpose markers to high-specificity molecular imaging markers. As early cancer screening, therapeutic monitoring, and companion diagnostics gain traction, there is growing clinical need for radiological markers with higher resolution, lower dosage, and stronger binding capability. Pharmaceutical companies increasingly rely on radiological markers for evaluating drug distribution and pharmacokinetics, making them strategic assets for R&D collaboration. Additionally, the evolution of multi-modal imaging is broadening the application scope of radiological markers.

Core upstream materials include radioactive isotopes, chelating agents, and biomolecular carriers. Their purity, stability, and availability directly influence product quality and imaging performance. Due to the unique production requirements of isotopes, the upstream supply landscape remains limited and concentrated, pushing companies to focus on supply chain robustness and raw-material traceability. To meet the growing demand for high-performance markers, upstream suppliers are accelerating innovation in isotope purity, half-life control, and biocompatibility. Advancements at the raw-material level are becoming an important driver of overall industry value enhancement.

This report aims to provide a comprehensive presentation of the global market for Radiological Marker, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Radiological Marker.

The Radiological Marker market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Radiological Marker market comprehensively. Regional market sizes, concerning products by Type, by Application, by Imaging Modality and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Radiological Marker companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Radiological Marker Market Report

Report Metric	Details
Report Name	Radiological Marker Market
Accounted market size in year	US$ 4438 million
Forecasted market size in 2031	US$ 7270 million
CAGR	7.4%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Small-Molecule Contrast Agents Radiotracers Other
Segment by Imaging Modality	PET Radiotracers SPECT Radiopharmaceuticals Other
Segment by Administration	Intravenous (IV) Administration Local Injection/Perfusion Oral Contrast
Segment by Application	Hospital Image Center Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Cardinal Health, GE Healthcare, Lantheus Medical Imaging, Bracco Imaging, Curium Pharma, Jubilant Pharmova, Aurobindo Pharma, Siemens, NTP Radioisotopes, ANSTO, Polatom, China Isotope & Radiation, Yantai Dongcheng, Seed Medical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, by Imaging Modality etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Radiological Marker company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Radiological Marker Market growing?

Ans: The Radiological Marker Market witnessing a CAGR of 7.4% during the forecast period 2025-2031.

What is the Radiological Marker Market size in 2031?

Ans: The Radiological Marker Market size in 2031 will be US$ 7270 million.

Who are the main players in the Radiological Marker Market report?

Ans: The main players in the Radiological Marker Market are Cardinal Health, GE Healthcare, Lantheus Medical Imaging, Bracco Imaging, Curium Pharma, Jubilant Pharmova, Aurobindo Pharma, Siemens, NTP Radioisotopes, ANSTO, Polatom, China Isotope & Radiation, Yantai Dongcheng, Seed Medical

What are the Application segmentation covered in the Radiological Marker Market report?

Ans: The Applications covered in the Radiological Marker Market report are Hospital, Image Center, Other

What are the Type segmentation covered in the Radiological Marker Market report?

Ans: The Types covered in the Radiological Marker Market report are Small-Molecule Contrast Agents, Radiotracers, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Radiological Marker Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Small-Molecule Contrast Agents

1.2.3 Radiotracers

1.2.4 Other

1.3 Market by Imaging Modality

1.3.1 Global Radiological Marker Market Size Growth Rate by Imaging Modality: 2020 VS 2024 VS 2031

1.3.2 PET Radiotracers

1.3.3 SPECT Radiopharmaceuticals

1.3.4 Other

1.4 Market by Administration

1.4.1 Global Radiological Marker Market Size Growth Rate by Administration: 2020 VS 2024 VS 2031

1.4.2 Intravenous (IV) Administration

1.4.3 Local Injection/Perfusion

1.4.4 Oral Contrast

1.5 Market by Application

1.5.1 Global Radiological Marker Market Growth by Application: 2020 VS 2024 VS 2031

1.5.2 Hospital

1.5.3 Image Center

1.5.4 Other

1.6 Assumptions and Limitations

1.7 Study Objectives

1.8 Years Considered

2 Global Growth Trends

2.1 Global Radiological Marker Market Perspective (2020-2031)

2.2 Global Radiological Marker Growth Trends by Region

2.2.1 Global Radiological Marker Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Radiological Marker Historic Market Size by Region (2020-2025)

2.2.3 Radiological Marker Forecasted Market Size by Region (2026-2031)

2.3 Radiological Marker Market Dynamics

2.3.1 Radiological Marker Industry Trends

2.3.2 Radiological Marker Market Drivers

2.3.3 Radiological Marker Market Challenges

2.3.4 Radiological Marker Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Radiological Marker Players by Revenue

3.1.1 Global Top Radiological Marker Players by Revenue (2020-2025)

3.1.2 Global Radiological Marker Revenue Market Share by Players (2020-2025)

3.2 Global Top Radiological Marker Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Radiological Marker Revenue

3.4 Global Radiological Marker Market Concentration Ratio

3.4.1 Global Radiological Marker Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Radiological Marker Revenue in 2024

3.5 Global Key Players of Radiological Marker Head office and Area Served

3.6 Global Key Players of Radiological Marker, Product and Application

3.7 Global Key Players of Radiological Marker, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Radiological Marker Breakdown Data by Type

4.1 Global Radiological Marker Historic Market Size by Type (2020-2025)

4.2 Global Radiological Marker Forecasted Market Size by Type (2026-2031)

5 Radiological Marker Breakdown Data by Application

5.1 Global Radiological Marker Historic Market Size by Application (2020-2025)

5.2 Global Radiological Marker Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Radiological Marker Market Size (2020-2031)

6.2 North America Radiological Marker Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Radiological Marker Market Size by Country (2020-2025)

6.4 North America Radiological Marker Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Radiological Marker Market Size (2020-2031)

7.2 Europe Radiological Marker Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Radiological Marker Market Size by Country (2020-2025)

7.4 Europe Radiological Marker Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Radiological Marker Market Size (2020-2031)

8.2 Asia-Pacific Radiological Marker Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Radiological Marker Market Size by Region (2020-2025)

8.4 Asia-Pacific Radiological Marker Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Radiological Marker Market Size (2020-2031)

9.2 Latin America Radiological Marker Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Radiological Marker Market Size by Country (2020-2025)

9.4 Latin America Radiological Marker Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Radiological Marker Market Size (2020-2031)

10.2 Middle East & Africa Radiological Marker Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Radiological Marker Market Size by Country (2020-2025)

10.4 Middle East & Africa Radiological Marker Market Size by Country (2026-2031)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Cardinal Health

11.1.1 Cardinal Health Company Details

11.1.2 Cardinal Health Business Overview

11.1.3 Cardinal Health Radiological Marker Introduction

11.1.4 Cardinal Health Revenue in Radiological Marker Business (2020-2025)

11.1.5 Cardinal Health Recent Development

11.2 GE Healthcare

11.2.1 GE Healthcare Company Details

11.2.2 GE Healthcare Business Overview

11.2.3 GE Healthcare Radiological Marker Introduction

11.2.4 GE Healthcare Revenue in Radiological Marker Business (2020-2025)

11.2.5 GE Healthcare Recent Development

11.3 Lantheus Medical Imaging

11.3.1 Lantheus Medical Imaging Company Details

11.3.2 Lantheus Medical Imaging Business Overview

11.3.3 Lantheus Medical Imaging Radiological Marker Introduction

11.3.4 Lantheus Medical Imaging Revenue in Radiological Marker Business (2020-2025)

11.3.5 Lantheus Medical Imaging Recent Development

11.4 Bracco Imaging

11.4.1 Bracco Imaging Company Details

11.4.2 Bracco Imaging Business Overview

11.4.3 Bracco Imaging Radiological Marker Introduction

11.4.4 Bracco Imaging Revenue in Radiological Marker Business (2020-2025)

11.4.5 Bracco Imaging Recent Development

11.5 Curium Pharma

11.5.1 Curium Pharma Company Details

11.5.2 Curium Pharma Business Overview

11.5.3 Curium Pharma Radiological Marker Introduction

11.5.4 Curium Pharma Revenue in Radiological Marker Business (2020-2025)

11.5.5 Curium Pharma Recent Development

11.6 Jubilant Pharmova

11.6.1 Jubilant Pharmova Company Details

11.6.2 Jubilant Pharmova Business Overview

11.6.3 Jubilant Pharmova Radiological Marker Introduction

11.6.4 Jubilant Pharmova Revenue in Radiological Marker Business (2020-2025)

11.6.5 Jubilant Pharmova Recent Development

11.7 Aurobindo Pharma

11.7.1 Aurobindo Pharma Company Details

11.7.2 Aurobindo Pharma Business Overview

11.7.3 Aurobindo Pharma Radiological Marker Introduction

11.7.4 Aurobindo Pharma Revenue in Radiological Marker Business (2020-2025)

11.7.5 Aurobindo Pharma Recent Development

11.8 Siemens

11.8.1 Siemens Company Details

11.8.2 Siemens Business Overview

11.8.3 Siemens Radiological Marker Introduction

11.8.4 Siemens Revenue in Radiological Marker Business (2020-2025)

11.8.5 Siemens Recent Development

11.9 NTP Radioisotopes

11.9.1 NTP Radioisotopes Company Details

11.9.2 NTP Radioisotopes Business Overview

11.9.3 NTP Radioisotopes Radiological Marker Introduction

11.9.4 NTP Radioisotopes Revenue in Radiological Marker Business (2020-2025)

11.9.5 NTP Radioisotopes Recent Development

11.10 ANSTO

11.10.1 ANSTO Company Details

11.10.2 ANSTO Business Overview

11.10.3 ANSTO Radiological Marker Introduction

11.10.4 ANSTO Revenue in Radiological Marker Business (2020-2025)

11.10.5 ANSTO Recent Development

11.11 Polatom

11.11.1 Polatom Company Details

11.11.2 Polatom Business Overview

11.11.3 Polatom Radiological Marker Introduction

11.11.4 Polatom Revenue in Radiological Marker Business (2020-2025)

11.11.5 Polatom Recent Development

11.12 China Isotope & Radiation

11.12.1 China Isotope & Radiation Company Details

11.12.2 China Isotope & Radiation Business Overview

11.12.3 China Isotope & Radiation Radiological Marker Introduction

11.12.4 China Isotope & Radiation Revenue in Radiological Marker Business (2020-2025)

11.12.5 China Isotope & Radiation Recent Development

11.13 Yantai Dongcheng

11.13.1 Yantai Dongcheng Company Details

11.13.2 Yantai Dongcheng Business Overview

11.13.3 Yantai Dongcheng Radiological Marker Introduction

11.13.4 Yantai Dongcheng Revenue in Radiological Marker Business (2020-2025)

11.13.5 Yantai Dongcheng Recent Development

11.14 Seed Medical

11.14.1 Seed Medical Company Details

11.14.2 Seed Medical Business Overview

11.14.3 Seed Medical Radiological Marker Introduction

11.14.4 Seed Medical Revenue in Radiological Marker Business (2020-2025)

11.14.5 Seed Medical Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Cardinal Health

GE Healthcare

Lantheus Medical Imaging

China Isotope & Radiation

Yantai Dongcheng

Seed Medical

List of Tables

Table 1. Global Radiological Marker Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Small-Molecule Contrast Agents

Table 3. Key Players of Radiotracers

Table 4. Key Players of Other

Table 5. Global Radiological Marker Market Size Growth Rate by Imaging Modality (US$ Million): 2020 VS 2024 VS 2031

Table 6. Key Players of PET Radiotracers

Table 7. Key Players of SPECT Radiopharmaceuticals

Table 8. Key Players of Other

Table 9. Global Radiological Marker Market Size Growth Rate by Administration (US$ Million): 2020 VS 2024 VS 2031

Table 10. Key Players of Intravenous (IV) Administration

Table 11. Key Players of Local Injection/Perfusion

Table 12. Key Players of Oral Contrast

Table 13. Global Radiological Marker Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 14. Global Radiological Marker Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 15. Global Radiological Marker Market Size by Region (2020-2025) & (US$ Million)

Table 16. Global Radiological Marker Market Share by Region (2020-2025)

Table 17. Global Radiological Marker Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 18. Global Radiological Marker Market Share by Region (2026-2031)

Table 19. Radiological Marker Market Trends

Table 20. Radiological Marker Market Drivers

Table 21. Radiological Marker Market Challenges

Table 22. Radiological Marker Market Restraints

Table 23. Global Radiological Marker Revenue by Players (2020-2025) & (US$ Million)

Table 24. Global Radiological Marker Market Share by Players (2020-2025)

Table 25. Global Top Radiological Marker Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiological Marker as of 2024)

Table 26. Ranking of Global Top Radiological Marker Companies by Revenue (US$ Million) in 2024

Table 27. Global 5 Largest Players Market Share by Radiological Marker Revenue (CR5 and HHI) & (2020-2025)

Table 28. Global Key Players of Radiological Marker, Headquarters and Area Served

Table 29. Global Key Players of Radiological Marker, Product and Application

Table 30. Global Key Players of Radiological Marker, Date of Enter into This Industry

Table 31. Mergers & Acquisitions, Expansion Plans

Table 32. Global Radiological Marker Market Size by Type (2020-2025) & (US$ Million)

Table 33. Global Radiological Marker Revenue Market Share by Type (2020-2025)

Table 34. Global Radiological Marker Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 35. Global Radiological Marker Revenue Market Share by Type (2026-2031)

Table 36. Global Radiological Marker Market Size by Application (2020-2025) & (US$ Million)

Table 37. Global Radiological Marker Revenue Market Share by Application (2020-2025)

Table 38. Global Radiological Marker Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 39. Global Radiological Marker Revenue Market Share by Application (2026-2031)

Table 40. North America Radiological Marker Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. North America Radiological Marker Market Size by Country (2020-2025) & (US$ Million)

Table 42. North America Radiological Marker Market Size by Country (2026-2031) & (US$ Million)

Table 43. Europe Radiological Marker Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Europe Radiological Marker Market Size by Country (2020-2025) & (US$ Million)

Table 45. Europe Radiological Marker Market Size by Country (2026-2031) & (US$ Million)

Table 46. Asia-Pacific Radiological Marker Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 47. Asia-Pacific Radiological Marker Market Size by Region (2020-2025) & (US$ Million)

Table 48. Asia-Pacific Radiological Marker Market Size by Region (2026-2031) & (US$ Million)

Table 49. Latin America Radiological Marker Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 50. Latin America Radiological Marker Market Size by Country (2020-2025) & (US$ Million)

Table 51. Latin America Radiological Marker Market Size by Country (2026-2031) & (US$ Million)

Table 52. Middle East & Africa Radiological Marker Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 53. Middle East & Africa Radiological Marker Market Size by Country (2020-2025) & (US$ Million)

Table 54. Middle East & Africa Radiological Marker Market Size by Country (2026-2031) & (US$ Million)

Table 55. Cardinal Health Company Details

Table 56. Cardinal Health Business Overview

Table 57. Cardinal Health Radiological Marker Product

Table 58. Cardinal Health Revenue in Radiological Marker Business (2020-2025) & (US$ Million)

Table 59. Cardinal Health Recent Development

Table 60. GE Healthcare Company Details

Table 61. GE Healthcare Business Overview

Table 62. GE Healthcare Radiological Marker Product

Table 63. GE Healthcare Revenue in Radiological Marker Business (2020-2025) & (US$ Million)

Table 64. GE Healthcare Recent Development

Table 65. Lantheus Medical Imaging Company Details

Table 66. Lantheus Medical Imaging Business Overview

Table 67. Lantheus Medical Imaging Radiological Marker Product

Table 68. Lantheus Medical Imaging Revenue in Radiological Marker Business (2020-2025) & (US$ Million)

Table 69. Lantheus Medical Imaging Recent Development

Table 70. Bracco Imaging Company Details

Table 71. Bracco Imaging Business Overview

Table 72. Bracco Imaging Radiological Marker Product

Table 73. Bracco Imaging Revenue in Radiological Marker Business (2020-2025) & (US$ Million)

Table 74. Bracco Imaging Recent Development

Table 75. Curium Pharma Company Details

Table 76. Curium Pharma Business Overview

Table 77. Curium Pharma Radiological Marker Product

Table 78. Curium Pharma Revenue in Radiological Marker Business (2020-2025) & (US$ Million)

Table 79. Curium Pharma Recent Development

Table 80. Jubilant Pharmova Company Details

Table 81. Jubilant Pharmova Business Overview

Table 82. Jubilant Pharmova Radiological Marker Product

Table 83. Jubilant Pharmova Revenue in Radiological Marker Business (2020-2025) & (US$ Million)

Table 84. Jubilant Pharmova Recent Development

Table 85. Aurobindo Pharma Company Details

Table 86. Aurobindo Pharma Business Overview

Table 87. Aurobindo Pharma Radiological Marker Product

Table 88. Aurobindo Pharma Revenue in Radiological Marker Business (2020-2025) & (US$ Million)

Table 89. Aurobindo Pharma Recent Development

Table 90. Siemens Company Details

Table 91. Siemens Business Overview

Table 92. Siemens Radiological Marker Product

Table 93. Siemens Revenue in Radiological Marker Business (2020-2025) & (US$ Million)

Table 94. Siemens Recent Development

Table 95. NTP Radioisotopes Company Details

Table 96. NTP Radioisotopes Business Overview

Table 97. NTP Radioisotopes Radiological Marker Product

Table 98. NTP Radioisotopes Revenue in Radiological Marker Business (2020-2025) & (US$ Million)

Table 99. NTP Radioisotopes Recent Development

Table 100. ANSTO Company Details

Table 101. ANSTO Business Overview

Table 102. ANSTO Radiological Marker Product

Table 103. ANSTO Revenue in Radiological Marker Business (2020-2025) & (US$ Million)

Table 104. ANSTO Recent Development

Table 105. Polatom Company Details

Table 106. Polatom Business Overview

Table 107. Polatom Radiological Marker Product

Table 108. Polatom Revenue in Radiological Marker Business (2020-2025) & (US$ Million)

Table 109. Polatom Recent Development

Table 110. China Isotope & Radiation Company Details

Table 111. China Isotope & Radiation Business Overview

Table 112. China Isotope & Radiation Radiological Marker Product

Table 113. China Isotope & Radiation Revenue in Radiological Marker Business (2020-2025) & (US$ Million)

Table 114. China Isotope & Radiation Recent Development

Table 115. Yantai Dongcheng Company Details

Table 116. Yantai Dongcheng Business Overview

Table 117. Yantai Dongcheng Radiological Marker Product

Table 118. Yantai Dongcheng Revenue in Radiological Marker Business (2020-2025) & (US$ Million)

Table 119. Yantai Dongcheng Recent Development

Table 120. Seed Medical Company Details

Table 121. Seed Medical Business Overview

Table 122. Seed Medical Radiological Marker Product

Table 123. Seed Medical Revenue in Radiological Marker Business (2020-2025) & (US$ Million)

Table 124. Seed Medical Recent Development

Table 125. Research Programs/Design for This Report

Table 126. Key Data Information from Secondary Sources

Table 127. Key Data Information from Primary Sources

Table 128. Authors List of This Report

List of Figures

Figure 1. Radiological Marker Picture

Figure 2. Global Radiological Marker Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Radiological Marker Market Share by Type: 2024 VS 2031

Figure 4. Small-Molecule Contrast Agents Features

Figure 5. Radiotracers Features

Figure 6. Other Features

Figure 7. Global Radiological Marker Market Size Comparison by Imaging Modality (2020-2031) & (US$ Million)

Figure 8. PET Radiotracers Features

Figure 9. SPECT Radiopharmaceuticals Features

Figure 10. Other Features

Figure 11. Global Radiological Marker Market Size Comparison by Administration (2020-2031) & (US$ Million)

Figure 12. Intravenous (IV) Administration Features

Figure 13. Local Injection/Perfusion Features

Figure 14. Oral Contrast Features

Figure 15. Global Radiological Marker Market Size by Application (2020-2031) & (US$ Million)

Figure 16. Global Radiological Marker Market Share by Application: 2024 VS 2031

Figure 17. Hospital Case Studies

Figure 18. Image Center Case Studies

Figure 19. Other Case Studies

Figure 20. Radiological Marker Report Years Considered

Figure 21. Global Radiological Marker Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 22. Global Radiological Marker Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 23. Global Radiological Marker Market Share by Region: 2024 VS 2031

Figure 24. Global Radiological Marker Market Share by Players in 2024

Figure 25. Global Radiological Marker Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 26. The Top 10 and 5 Players Market Share by Radiological Marker Revenue in 2024

Figure 27. North America Radiological Marker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. North America Radiological Marker Market Share by Country (2020-2031)

Figure 29. United States Radiological Marker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Canada Radiological Marker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Europe Radiological Marker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Europe Radiological Marker Market Share by Country (2020-2031)

Figure 33. Germany Radiological Marker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. France Radiological Marker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. U.K. Radiological Marker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Italy Radiological Marker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Russia Radiological Marker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Ireland Radiological Marker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Asia-Pacific Radiological Marker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Asia-Pacific Radiological Marker Market Share by Region (2020-2031)

Figure 41. China Radiological Marker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Japan Radiological Marker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. South Korea Radiological Marker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Southeast Asia Radiological Marker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. India Radiological Marker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Australia & New Zealand Radiological Marker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Latin America Radiological Marker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Latin America Radiological Marker Market Share by Country (2020-2031)

Figure 49. Mexico Radiological Marker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Brazil Radiological Marker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Middle East & Africa Radiological Marker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. Middle East & Africa Radiological Marker Market Share by Country (2020-2031)

Figure 53. Israel Radiological Marker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 54. Saudi Arabia Radiological Marker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 55. UAE Radiological Marker Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 56. Cardinal Health Revenue Growth Rate in Radiological Marker Business (2020-2025)

Figure 57. GE Healthcare Revenue Growth Rate in Radiological Marker Business (2020-2025)

Figure 58. Lantheus Medical Imaging Revenue Growth Rate in Radiological Marker Business (2020-2025)

Figure 59. Bracco Imaging Revenue Growth Rate in Radiological Marker Business (2020-2025)

Figure 60. Curium Pharma Revenue Growth Rate in Radiological Marker Business (2020-2025)

Figure 61. Jubilant Pharmova Revenue Growth Rate in Radiological Marker Business (2020-2025)

Figure 62. Aurobindo Pharma Revenue Growth Rate in Radiological Marker Business (2020-2025)

Figure 63. Siemens Revenue Growth Rate in Radiological Marker Business (2020-2025)

Figure 64. NTP Radioisotopes Revenue Growth Rate in Radiological Marker Business (2020-2025)

Figure 65. ANSTO Revenue Growth Rate in Radiological Marker Business (2020-2025)

Figure 66. Polatom Revenue Growth Rate in Radiological Marker Business (2020-2025)

Figure 67. China Isotope & Radiation Revenue Growth Rate in Radiological Marker Business (2020-2025)

Figure 68. Yantai Dongcheng Revenue Growth Rate in Radiological Marker Business (2020-2025)

Figure 69. Seed Medical Revenue Growth Rate in Radiological Marker Business (2020-2025)

Figure 70. Bottom-up and Top-down Approaches for This Report

Figure 71. Data Triangulation

Figure 72. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions